No Data
Returns On Capital At Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Have Hit The Brakes
China Galaxy Securities: The AI Medical sector is experiencing a resurgence, with DeepSeek applications having a profound impact.
From the perspective of AI Medical applications, new drug development, equipment intelligence, diagnostic services, and Physical Examination services are expected to advance rapidly, promising to continuously enhance the valuation of the Medical Sector.
China Galaxy Securities: Deepseek is sparking a trend in AI Medical, which is expected to continuously enhance the valuation of the Medical Sector.
Medical is one of the most important and promising scenarios for AI applications, primarily centered on the resonance between AI large model inference capabilities and Medical Big Data. Industry pharmaceutical companies are rapidly deploying localized applications of deepseek, significantly enhancing the performance of specialized large models.
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
Huachuang Securities Starts Jiangsu Yuyue Medical Equipment & Supply at Buy With 48 Yuan Price Target
Research Reports gold mining丨China Alliance Securities: Jiangsu Yuyue Medical Equipment & Supply's new Global Strategy focuses on three core tracks, initially giving a "recommended" rating.
According to a Research Report from Huachuang Securities, Jiangsu Yuyue Medical Equipment & Supply (002223.SZ) is a well-established domestic leader in home medical instruments, transitioning from "expansion" to "focus" and entering a stage of refined development. The company's new Global Strategy focuses on three core tracks, which are expected to unlock growth potential for the company. At the same time, the company is actively incubating high-potential businesses, rapidly advancing overseas operations, and leveraging online channels; in the post-pandemic era, the company's sustainable development drivers are strong. Considering the high growth potential of the company’s three core business lines and the future volume potential of high-potential businesses, a valuation of 21 times PE for 2025 is given, corresponding to the target.
Do Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Earnings Warrant Your Attention?
